A subset of patients with myeloproliferative neoplasms (MPNs) -- clonal disorders of hematopoietic stem cells that include polycythemia vera and essential thrombocythemia, as well as primary ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Pankit Vachhani, ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. As a ...

Multiple myeloma and myelofibrosis are both rare blood cancers. But they have distinct features that set them apart from one another. Though it’s unusual, you can develop these two cancers at the same ...

Allogeneic stem cell transplant is the only treatment that has the potential to cure myelofibrosis. "It's very important to include stem cell transplant in 2024 -- and beyond -- in every conversation, ...

Myelofibrosis can already be treated with several drugs from a class of medicines that address a pathway driving this type of blood cancer. A drug from GSK is now the latest entrant into the class, ...

LONDON--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk ...

Jason Weiner has benefited from the opportunity to participate in a myelofibrosis clinical trial at MSK. He is shown here with his wife, Cori, children Dominik, Kasia, and Damian, and dog Babka around ...

Myelofibrosis-related anemia is different than anemia experienced by patients without a cancer diagnosis, a research nurse explained. Anemia is a common and potentially dangerous condition that can ...

NEWTON, Mass., Sept. 10, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has ...